Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
Murakami M, Ishikawa H, Sekino Y, Nishiyama H, Suzuki H, Sugahara S, Iizumi T, Mizumoto M, Okumura T, Keino N, Iizumi Y, Hashimoto K, Gosho M, Sakurai H.
Murakami M, et al.
J Radiat Res. 2024 May 12:rrae026. doi: 10.1093/jrr/rrae026. Online ahead of print.
J Radiat Res. 2024.
PMID: 38739903